Study #1: Oxaloacetate Reduces Fatigue by Over 25% in ME/CFS Patients
A preliminary 2024 randomized placebo-controlled study in ME/CFS patients found a statistically significant >25% average reduction in fatigue in those taking oxaloacetate, compared to a non-significant ~10% reduction in the placebo group. Additionally, 40% of participants were “super responders,” experiencing an average fatigue reduction of 63%.
